United States Securities and Exchange Commission · EDGAR Accession 0002053710-26-000001

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-35524
Issuer CIK 2053710
Raising via DEALMAKER SECURITIES LLC

RAM Pharmaceuticals Inc.

CorporationMSIncorporated 2024LUMBERTON, MSrampharmaceuticals.com
Nature of amendmentChanges to Landing Page
A

The Offering

as disclosed in this filing
Common Stock
$1.00
$10,000
$1,235,000
April 1, 2026
Expired 74 days ago
$0max $1,235,000

Target is 1% of the maximum. Over-subscriptions accepted, allocated first-come, first-served basis.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 220%1 employee
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(33,481)0
Total assets27,8570
Cash & equivalents23,4380
Accounts receivable7,4450
Short-term debt61,3380
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-35524 · all filings under this campaign
Loading campaign history…